Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-101-2 | CAS number: 115-70-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 1982
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
Materials and methods
- Principles of method if other than guideline:
- Intradermal skin sensitising study. Guinea pigs injected into dermis with test substance or positive/negative control substance every 48 hours for 10 applications. Challenged at 2 weeks after final injection with injectionof test material at a virgin site. Scores for erythema and edema at 24 and 48 hours post challenge to assess sensitising response.
- GLP compliance:
- not specified
- Type of study:
- intracutaneous test
- Justification for non-LLNA method:
- Existing study conducted in 1982.
Test material
- Reference substance name:
- 2-amino-2-ethylpropanediol
- EC Number:
- 204-101-2
- EC Name:
- 2-amino-2-ethylpropanediol
- Cas Number:
- 115-70-8
- Molecular formula:
- C5H13NO2
- IUPAC Name:
- 2-amino-2-ethylpropane-1,3-diol
- Reference substance name:
- 2-Amino-2-ethyl-1,3-propanediol
- IUPAC Name:
- 2-Amino-2-ethyl-1,3-propanediol
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- - AEPD Lot No.: NPP-41344
- 2-Amino-2-ethyl-1,3-propanediol: 85.34 wt%
- Methanol: 1.48 wt%
- Monomethyl amino butanol: 10.92 wt%
- Water: 1.89 wt%
- pH at 100%: 11.78
- pH 1% solution: 11.18
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal
- Vehicle:
- water
- Concentration / amount:
- first 5 induction injections with a 1% aqueous solutionof AEPD, remaining 5 injections with a 0.05% aqueous solution of AEPD.
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- No.:
- #1
- Route:
- intradermal
- Vehicle:
- water
- Concentration / amount:
- Challenge injection with 0.05 and 0.01% injections (at different virgin sites)
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- 10
- Details on study design:
- The intradermal sensitisation study with AEPD (P-1050) was conducted in male guinea pigs according to Landsteiner and Jacobs procedure (Landsteiner, K., and J. Jacobs. "Studies on Sensitization of Animals with Simple Chemical Compounds." J. Exp. Med. -61: 643-656, 1935). Forty male guinea pigs weighing 250 to 300 g were divided into four groups of 10 each. The animals' backs and flanks were shaved free of hair. Group XIV was intradermally injected with 0.05 ml of 1% solution of P-1050 in saline. Group V (positive control) was similarly injected with 0.05 ml of 0.3% dinitrochlorobenzene (DNCB) solution (solubilized in minimum volume of alcohol and made to volume with saline). Groups XVI and XVII (negative controls) were injected with 0.05 ml of saline. After 24 hours and 48 hours the injected sites scored for erythema edema, according to Draize. At 48 hours, the intradermal injection procedure was repeated for each group with 0.1 ml of each solution two or three times a week until a total of 10 injections have been made. After the last injection, the animals were allowed to rest for two weeks. On the first day of the third week (or the 35th day after the first injection), the animals in each group were challenged intradennally with 0.1 m l of solution at a virgin site. Group XIV and Group XVII animals were challenged with P-1050 solution (0.05 and 0.01%). Groups V and XVI animals were challenged with 0.03% DNCB solution. At the end of 24 h, the injected sites were depilated. Three hours after the removal of the hair , the injected sites were scored for inflammatory skin reactions (erythema and edema). The sites were re-scored at 48 hours (24 hours after the first scoring).
- Positive control substance(s):
- yes
- Remarks:
- dinitrochlorobenzene (DNCB) 0.3%
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Induction with saline; challenge with 0.01% solution of test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Induction with 0.9% saline; challenge with 0.05% solution of test substance
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- other: necrosis
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Induction with 0.9% saline; challenge with 0.03% solution of DNCB
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Induction with 0.9% saline; challenge with 0.03% solution of DNCB
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Induction with test substance; challenge with 0.01% solution of test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Induction with test substance; challenge with 0.01% solution of test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Induction with test substance; challenge with 0.05% solution of test substance
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- other: necrosis
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Induction with test substance; challenge with 0.05% solution of test substance
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- other: necrosis
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- Induction with 0.3% DNCB; challenge with 0.3% DNCB
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- Induction with 0.3% DNCB: challenge with 0.3% DNCB
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
During the induction phase the guinea pigs in the test group showed some skin reactions with AEPD (P-1050). The first five injections were made with 1% solution and the last five injections were made with 0.05% solution. None of the negative control animals showed any skin reactions. The positive control animals showed mild to necrotic skin reactions during the entire induction period. At challenge with 0.05% of AEPD, all the animals in the treatment group and the negative control group showed skin reactions, but none of the animals in either group showed any skin reactions with 0.01% solution. The DNCB (0.03%) eluted positive skin reactions in the positive control group and in some animals in the negative control group.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Conclusions:
- Undiluted AEPD was found to be a non-sensitizer when tested in the guinea pig (intradermal application).
- Executive summary:
An intradermal sensitization test was conducted by injecting an AEPD solution (P-1050) intradermally in male guinea pigs according to Landsteiner and Jacobs procedure (Landsteiner, K., and J. Jacobs. "Studies on Sensitization of Animals with Simple Chemical Compounds." J. Exp. Med. -61: 643-656, 1935). Forty male guinea pigs weighing 250 to 300 g were divided into four groups of 10 each. The animals' backs and flanks were shaved free of hair. Group XIV was intradermally injected with 0.05 ml of 1% solution of P-1050 in saline. Group V (positive control) was similarly injected with 0.05 ml of 0.3% dinitrochlorobenzene (DNCB) solution (solubilized in minimum volume of alcohol and made to volume with saline). Groups XVI and XVII (negative controls) were injected with 0.05 ml of saline. After 24 hours and 48 hours the injected sites scored for erythema edema, according to Draize. At 48 hours, the intradermal injection procedure was repeated for each group with 0.1 ml of each solution two or three times a week until a total of 10 injections have been made. After the last injectio n , the animals were allowed to rest for two weeks. On the first day of the third week (or the 35th day after the first injection), the animals in each group were challenged intradennally with 0.1 m l of solution at a virgin site. Group XIV and Group XVII animals were challenged with P-1050 solution (0.05 and 0.01%). Groups V and XVI animals were challenged with 0.03% DNCB solution. At the end of 24 h, the injected sites were depilated. Three hours after the removal of the hair , the injected sites were scored for inflammatory skin reactions (erythema and edema). The sites were re-scored at 48 hours (24 hours after the first scoring).
During the induction phase the guinea pigs i n Group XIV showed some skin reactions with P-1050. The first five injections were made w i t h 1% solution and the last five injections were made with 0.05% solution. None of the animals in Groups XVI and XVII (negative controls) showed any skin reactions. The animals in Group V (positive control ) showed mild to necrotic skin reactions during the entire induction period. At challenge with 0.05% of P-1050, all the animals i n Group IV (treatment) and Group XVII (negative control) showed skin reactions, but none of the animals in either group showed any skin reactions with 0.01% solution. The DNCB (0.03%) eluted positive skin reactions in Group V (positive control group) and in some animals in Group XVI (negative control group).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.